IMNM Operating Cash Flow (Statement)
Immunome Inc · Operating Cash Flow (Statement)
IMNM Operating Cash Flow (Statement)
Latest reported-$208.79Mperiod ending
IMNM Cash from Operations (-$7.41M → -$208.79M)
Annual operating cash flow (statement)
High-resolution chart · PNG
IMNM operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -190,919,000 | |
| -110,794,000 | |
| -7,568,000 | |
| -28,690,000 | |
| -18,226,000 | |
| -12,134,000 | |
| -9,600,000 | |
| -7,406,000 |